Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
DART-HA
NCT06218199Phase 4Recruiting
- Sponsor
- Heart Center Research
- Start
- Jul 2021
- Primary completion
- Dec 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of sacubitril + valsartan, furosemide, torasemide, bumetanide in heart failure (HF), sponsored by Heart Center Research. Started Jul 2021; status: recruiting.
02
Drugs
sacubitril + valsartanfurosemidetorasemidebumetanide
03
Conditions
heart failure (HF)
Beyond the preview
Go deeper on NCT06218199.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06218199.